Package leaflet: Information for the user Efedrin Stragen 3mg/ml, solution for injection Ephedrine hydrochloride

Similar documents
Ephedrine must be used solely by or under the supervision of the anaesthesiologist/anaesthetist.

Package leaflet: Information for the user. Atropin Stragen 0.1 mg/ml solution for injection in prefilled syringe.

PACKAGE LEAFLET: INFORMATION FOR THE USER. EPHEDRINE HCl STEROP 10mg/ml EPHEDRINE HCl STEROP 50mg/ml Solution for injection. Ephedrine Hydrochloride

Package leaflet: Information for the user

Ventolin Injection 500 micrograms/ml salbutamol sulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dopamine 40 mg/ml Sterile Concentrate

Package leaflet: Information for the patient. Chlorphenamine 10 mg/ml Solution for Injection (Chlorphenamine Maleate)

Package leaflet: Information for the user NON DROWSY SUDAFED. DECONGESTANT 60 mg FILM-COATED TABLETS Pseudoephedrine hydrochloride

Package leaflet: Information for the user. Novastan 100 mg/ml concentrate for solution for infusion. argatroban monohydrate

Package leaflet: Information for the user. Cyclizine Lactate 50 mg/ml Injection

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

PACKAGE LEAFLET: INFORMATION FOR THE USER. Active substance: enoximone

1. What Naropin is and what it is used for

Package leaflet: Information for the patient. xylometazoline hydrochloride

Package leaflet: Information for the patient. Morphine Unimedic 1 mg/ml solution for injection morphine hydrochloride trihydrate

Package leaflet: Information for the user. Exembol 1 mg/ml solution for infusion. argatroban monohydrate

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. Adrenaline

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml solution for injection/infusion Cisatracurium 5 mg/ml solution for injection/infusion

Package leaflet: Information for the user Glycopyrronium Bromide 200 micrograms/ml injection (Glycopyrronium Bromide)

Package leaflet: Information for the patient. Gemcitabine 10 mg/ml, solution for infusion. gemcitabine

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

Package leaflet: Information for the patient. Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Meptid 100 mg/ml Solution for Injection. Meptazinol

PATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human)

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. Otrivin Menthol (without preservative) 1 mg/ml nasal spray, solution Xylometazoline hydrochloride

Package leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid

Package leaflet: Information for the user. Lidocaine Hydrochloride Anhydrous 2% w/v Adrenaline (epinephrine) 1:80,000

Package leaflet: Information for the user. Chirocaine mg/ml or 1.25 mg/ml solution for infusion For epidural use only.

PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER. chloroprocaine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml Solution for Injection/Infusion Cisatracurium 5 mg/ml Solution for Injection/Infusion

Package leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate

Package leaflet: Information for the user. Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

Package leaflet: Information for the user. Portrazza 800 mg concentrate for solution for infusion necitumumab

Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride

Benylin Phlegm Cough plus Decongestant Syrup

Boots Decongestant Tablets with Paracetamol (Paracetamol, Pseudoephedrine Hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Dobutamine 12.5mg/ml Concentrate for Solution for Infusion Dobutamine Hydrochloride

Ultra Cold & Flu Relief All in One Capsules (Paracetamol, Guaifenesin, Phenylephrine Hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Xylo-COMOD

PACKAGE LEAFLET: INFORMATION FOR THE USER. Calcium Folinate 10 mg/ml Injection

Package leaflet: Information for the user

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin

Package leaflet: Information for the user. Nocdurna 25 microgram oral lyophilisate Nocdurna 50 microgram oral lyophilisate.

Package Leaflet: Information for the user

PATIENT INFORMATION LEAFLET. Nasoxyl nasal spray solution 1 mg/ml

Package Leaflet: Information for the User Zotron 4mg/2ml (ή 8mg/4ml) Solution for Injection or Infusion ondansetron

1. What Octostim Nasal Spray is and what it is used for

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH)

PHENYLEPHRINE. Please read this leaflet and the label of the medicine you purchased, carefully before you start using Phenylephrine.

Package leaflet: Information for the patient. Zerbaxa 1 g / 0.5 g powder for concentrate for solution for infusion ceftolozane / tazobactam

Package Leaflet: Information for the user Kemadrin 5 mg Tablets Procyclidine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Human Albumin Biotest 20%, solution for infusion Human albumin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Xylonase 0.1% w/v Nasal Spray, Solution Xylometazoline hydrochloride

Package leaflet: Information for the patient. Selenium 10 micrograms/ml concentrate for solution for infusion. Sodium selenite

Ventolin Accuhaler 200 micrograms salbutamol sulfate

1. What Xylocaine with adrenaline is and what it is used for

Package leaflet: Information for the user. Bridion 100 mg/ml solution for injection sugammadex

Package leaflet: Information for the user. GlucaGen HypoKit 1 mg Powder and solvent for solution for injection Glucagon

Package leaflet: Information for the user. Tobramycin 40 mg/ml Solution for Injection tobramycin

Package leaflet: Information for the user. Optiray 320 mg I/ml, solution for injection or infusion. Active substance: Ioversol

Package leaflet: Information for the user

Package leaflet: Information for the user

Package leaflet: Information for the user. TRISENOX 1 mg/ml concentrate for solution for infusion arsenic trioxide

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes

Package leaflet: Information for the patient. Vyxeos 44 mg/100 mg powder for concentrate for solution for infusion daunorubicin and cytarabine

Package leaflet: Information for the patient. Bavencio 20 mg/ml concentrate for solution for infusion avelumab

PACKAGE LEAFLET: INFORMATION FOR THE USER. Meptid 100 mg/ml Solution for Injection. Meptazinol Hydrochloride

Package leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone

PACKAGE LEAFLET: INFORMATION FOR THE USER. Gemzar 200 mg powder for solution for infusion Gemzar 1000 mg powder for solution for infusion Gemcitabine

Package leaflet: Information for the patient. Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid

Non-Drowsy SUDAPLUS Tablets Paracetamol 500 mg Pseudoephedrine hydrochloride 30 mg

PACKAGE LEAFLET: INFORMATION FOR THE USER. Ropivakain Sintetica 5 mg/ml solution for injection ropivacaine hydrochloride

Package leaflet: Information for the user. Pharmalgen Bee Venom Pharmalgen Wasp Venom. 100μg/ml. powder and solvent for solution for injection

Package leaflet: Information for the patient. Trasylol 10,000 KIU/ml solution for injection or infusion. Aprotinin

Day Cold & Flu Relief Oral Solution (Paracetamol, Pholcodine, Pseudoephedrine Hydrochloride)

Package leaflet: information for the user. Prismasol 2 mmol/l Potassium Solution for haemodialysis/haemofiltration

Package leaflet: Information for the user. Methylthioninium chloride Proveblue 5 mg/ml solution for injection Methylthioninium chloride

Benylin Children's Coughs & Colds 5mg/0.625mg per 5ml Syrup dextromethorphan, triprolidine

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Dibondrin - Ampoules. Active substance: diphenhydramine hydrochloride

Package Leaflet : Information for the User. IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Variquel 1 mg powder and solvent for solution for injection Terlipressin acetate

Package leaflet: Information for the user. Morfin Abcur 10 mg/ml, solution for injection. morphine hydrochloride

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

PACKAGE LEAFLET: INFORMATION FOR THE USER. Zoledronic Acid 4 mg/5 ml concentrate for solution for infusion. Zoledronic acid

Dry Cough & Congestion Relief Oral Solution

Package leaflet: Information for the user. Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion

PACKAGE LEAFLET: INFORMATION FOR THE USER. Zoledronic Acid IBIGEN 4 mg powder and solvent for solution for infusion Zoledronic acid

ANNEX III LABELLING AND PACKAGE LEAFLET

Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:

Coldrex MaxGrip Lemon Powder for oral solution

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

Transcription:

Package leaflet: Information for the user Efedrin Stragen 3mg/ml, solution for injection Ephedrine hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this in this leaflet: 1. What Efedrin Stragen is and what it is used for 2. What you need to know before you are given Efedrin Stragen 3. How Efedrin Stragen is given 4. Possible side effects 5. How to store Efedrin Stragen 6. Contents of the pack and other information 1. What Efedrin Stragen is and what it is used for Efedrin Stragen is used to treat low blood pressure that can occur during different types of anaesthesia. This product must be used solely by or under the supervision of the anaesthetist. 2. What you need to know before you use Efedrin Stragen You can not be given Efedrin Stragen: - if you are allergic to ephedrine or to any of the other ingredients of this medicine (listed in section 6 ). Warnings and precautions You should inform your doctor if: - you have high blood pressure; - you suffer from heart disease or any other heart conditions; - you have diabetes; - you have an overactive thyroid gland - you have an enlarged prostate; - you know or suspect that you suffer from glaucoma (increased pressure inside the eye); - you are currently taking or have taken, within the last 14 days, any monoamine oxidase inhibitors medicine (MAOIs) used to treat depression. Other medicines and Efedrin Stragen Tell your doctor if you are taking or have recently taken or might use any other medicines. It is especially important to tell your doctor if you are taking the following medicines: - Antidepressant medicines, such as tricyclic antidepressant (e.g. imipramine) or serotoninergicnoradrenergic medicines (e.g. minalcipran, venlafaxine) or any monoamine oxidase inhibitors (e.g. moclobemide, toloxatone); - Medicines used to lower the blood pressure (e.g. guanethidine, clonidine); - Theophylline, a medicine used for respiratory diseases such as asthma; - Corticosteroids, which are medicines that reduce the inflammation and the consequences of allergic reactions;

- Sibutramine, an appetite suppressant that is administered orally for the treatment of obesity; - Linezolide, an antibiotic used for the treatment of serious infections; - Oxytocin, a medicine used during labour. - Some other anaesthetics and especially cyclopropane and halothane; - Some cough and cold medication that can elevate the blood pressure (phenylpropanolamine, pseudoephedrine, phenylephrine); - Methylphenidate, a medicine used for the treatment of attention deficit-hyperactivity disorder; - Some medicines used for the treatment of heart failure and/or irregular heartbeat (Cardiac glycosides, Quinidin) Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Efedrin Stragen may be used under caesarean section. You should suspend breast feeding for a few days after receiving this medicine. Efedrin Stragen contains sodium This medicine contains 3.32 mg (0.144 mmol) of sodium per ml of injection (a total of 33.2 mg or 1.44 mmol sodium in 10 ml syringe). This amount must be taken into consideration by patients on a salt-restricted diet. 3. How to use Efedrin Stragen Your doctor or nurse will give Efedrin Stragen to you into a vein (intravenous route). Your doctor will decide the correct dosage for you and when and how the injection should be administered. If you are given more Efedrin Stragen than you should having too much of Efedrin Stragen may lead to symptoms such as feeling sick (nausea), vomiting, fever, paranoid psychosis, irregular heart beat, high blood pressure, decreased rate of breathing, fits and coma. If these symptoms occur, you may require intensive supportive treatment. If you have any further questions on the use of this product, ask your doctor. For practical information on handling or administration of the medicinal product, please refer to the section for medical or healthcare professionals at the end of the leaflet. 4. Possible side effects Like all medicines, Efedrin Stragen can cause side effects, although not everybody gets them. Common (may affect up to 1 in 10 people): - confusion, anxiety, depression; - nervousness, irritability, restlessness, weakness, difficulty in sleeping (insomnia), headache, sweating; - feeling your heartbeat (palpitations), high blood pressure (hypertension), increased heart beat (tachycardia); - laboured breathing (dyspnoea); - feeling sick (nausea), vomiting. Rare (may affect up to 1 in 1.000 people): - irregular heart beat (cardiac arrhythmias); - lack of ability to urinate (acute urinary retention).

Not known (frequency cannot be estimated from the available data): - allergic reactions (hypersensitivity); - psychotic states, fear; - shaking (tremor), elevated production of saliva (hypersalivation); - episodes of angle-closure glaucoma (a disease in which the optic nerve is damaged); - chest pain, slower heart beat (reflex bradycardia), cardiac arrest, lower blood pressure (hypotension); - bleeding, within the skull (cerebral haemorrhage); - fluid accumulation in the lungs (pulmonary oedema); - reduced appetite; - low blood levels of potassium (hypokalaemia), which can cause muscle weakness, twitching or abnormal heart rhythm changes in blood glucose levels. Reporting of side effects If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Efedrin Stragen Keep out of the sight and reach of children. Do not use Efedrin Stragen after the expiry date which is stated on the carton and syringe label, after EXP. Your doctor or nurse will check this. Store the blister in the outer carton in order to protect from light. The pre-filled syringe is for single use only. After opening the product must be used immediately. Any unused product or waste material should be disposed of in accordance with local requirements. 6. Contents of the pack and other information What Efedrin Stragen contains - The active ingredient is ephedrine hydrochloride. Each ml of solution for injection contains 3 mg ephedrine hydrochloride. Each 10 ml prefilled syringe contains 30 mg ephedrine hydrochloride. - The other ingredients are sodium chloride, citric acid monohydrate, sodium citrate, water for injection, hydrochloric acid or sodium hydroxide (for ph adjustments). Each ml of solution for injection contains 3.32 mg sodium equivalent to 0.144 mmol. What Efedrin Stragen looks like and contents of the pack Efedrin Stragen is a clear and colourless solution. It is supplied in a 10 ml polypropylene prefilled syringe with a polypropylene tip cap and tamper proof seal, and is individually packaged in a transparent blister pack. The prefilled syringes are available in boxes of 10 or 12 syringes. Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder STRAGEN Nordic A/S Helsingørsgade 8C 3400 Hillerød Denmark Manufacturer: LABORATOIRE AGUETTANT 1, rue Alexander Fleming 69007 LYON CEDEX France This leaflet was last revised in 2016-10-12. <[To be completed nationally]> ----------------------------------------------------------------------------------------------------------------- The following information is intended for medical or healthcare professionals only: Instructions for use: Be careful to strictly respect the protocol for the use of the syringe. The pre-filled syringe is for single patient only. Discard syringe after use. DO NOT REUSE. The content of un-opened and un-damaged blister is sterile, and must not be opened until use. The product should be inspected visually for particles and discoloration prior to administration. Only clear colourless solution free from particles or precipitates should be used. Do not use the product if the tamper evident seal on syringe is broken. Using aseptic technique, Efedrin Stragen can be used on a sterile field. Withdraw the pre-filled syringe from the sterile blister. 1. Before opening the syringe, push firmly the piston rod in order to break loose the syringe plunger.

2. Twist off the tip cap to break the frangible obturator. 3. Check that the sealing cap has been completely removed. 4. Purge the air of the syringe by pushing the piston slightly. 5. Connect the syringe to the intravenous access. Push the piston carefully to inject the required volume. Any unused product or waste material should be disposed of in accordance with local requirements. Storage: After opening: the product must be used immediately. Store the blister in the outer carton in order to protect from light.